Prostaglandin E2 requirement for transforming growth factor β2 inhibition of elicited macrophage 14 kDa phospholipase A2 release

British Journal of Pharmacology

Volumn 116, Issue 6, 1995, Pages 2575-2581

  McCord, Mark ^a   Bolognese, Brian ^a   Marshall, Lisa A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

cyclo oxygenase; elicited peritoneal macrophage; Phospholipase A2; prostaglandin E2; transforming growth factor 1 indomethacin

Indexed keywords

FORSKOLIN; INDOMETACIN; PHOSPHOLIPASE A; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; ADENYLATE CYCLASE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; CELL CULTURE; CHO CELL; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HAMSTER; MALE; PERITONEUM MACROPHAGE; PHYSIOLOGY; SECRETION; ANIMAL CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; GUINEA PIG; INFLAMMATION; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FORSKOLIN; INDOMETHACIN; MACROPHAGES, PERITONEAL; MALE; PHOSPHOLIPASES A; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028973232     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb17210.x     Document Type: Article

References (42)

1. 2 in baculovirus‐infected inst cells
2. 2(s) by transforming growth factor‐β
3. 2 and arthitis
4. 2 induces an inflammatory response in rabbit joints
5. Prostaglandins and chronic inflammation
6. 2 with membrane in the macrophage cell line RAW 264.7
7. Rapid killing of actinomycin D‐treated tumor cells by human mono‐nuclear cells
8. 2 gene expression in human hepatoma cells by mediators of the acute phase response
9. 2 activity in cell free peritoneal lavage fluid from mice with zymosan peritonitis
10. 2
11. Are prostaglandins proinflammatory, antiinflammatory, both, or neither?
12. Control of lymphokine secretion by prostaglandins
13. Molecular mechanism of signal transduction in macrophages
14. Change in growth andmorphology of fibroblast by prostaglandins
15. 2
16. TGF‐β1 induces phosphorylation of the cyclic‐AMP responsive element binding protein in ML‐CCI64 cells
17. Cyclic AMP and the regulation of prostaglandin production by macrophages
18. 2
19. 2 release by elicited‐peritoneal macrophage and its relationship to eicosanoid production
20. 2 generated during glycogen‐induced rat peritonitis
21. 2 activities in human platelet, monocyte and neutrophil
22. Prostaglandins, aspirin‐like drugs and oedema of inflammation
23. 2 in rat cultured astrocytes
24. Receptor‐mediated signal transduction in mononuclear phagocytes
25. 2 by antisense and effects on endotoxin‐induced prostaglandin biosynthesis
26. 2 formation in rat mesangial cells
27. 2
28. Forskolin: Its biological and chemical properties
29. 2
30. The ways in which hormones change cyclic adenosine 3′,5′‐monophosphate‐dependent protein kinase subunits, and how such changes affect cell behavior
31. Some recent advances in the chemistry and biology of transforming growth factor‐beta. J
32. 2 expressed in Chinese hamster ovary cells. J
33. Inhibitory effect of prostaglandin E2, forskolin, and dibutyrl cAMP on arachidonic acid release and inositol phospholipid metabolism and guinea‐pig neutrophils
34. 2 negatively modulates induction of nitric oxide synthase by interleukin 1
35. Transforming growth factor type b monocyte Chemotaxis and growth factor production
36. Inflammatory and immunomodulatory roles of TGF‐b
37. Mechanisms of tissue injury in rheumatic diseases
38. Prostaglandins as modulators rather than mediators of inflammation
39. Inflammation, prostaglandins, and loss of function
40. Prostaglandins as potentiators of increased vascular permeability in inflammation